DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Schreiber S, Feagan B, D'Haens G et al.
Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial.
Clin Gastroenterol Hepatol 2006;
4: 325-334
We do not assume any responsibility for the contents of the web pages of other providers.